Clinical Trial Update: Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ipilimumab plus dacarbazine versus dacarbazine with placebo in untreated unresectable stage III or IV melanoma has completed, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• ipilimumab (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Melanoma | Phase 3 | Status: COMPLETED | Results posted: 2014-03-10